Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-05 10:51 am Unchanged | 13D | VIEW INC VIEW | Anson Funds Management LP | 441,703 9.9% | 0 (Unchanged) | View |
| 2024-02-14 4:25 pm Purchase | 13G | ISUN INC ISUN | Anson Funds Management LP | 3,500,000 9.3% | 3,500,000 (New Position) | View |
| 2024-02-14 4:25 pm Purchase | 13G | SPERO THERAPEUTICS INC SPRO | Anson Funds Management LP | 4,297,599 8.1% | 4,297,599 (New Position) | View |
| 2024-02-14 4:17 pm Purchase | 13G | XTI AEROSPACE INC XTIA | Anson Funds Management LP | 19,338,936 9.9% | 19,338,936 (New Position) | View |
| 2024-02-14 4:15 pm Sale | 13G | Trilogy International Partners Inc. TRL | Anson Funds Management LP | 8,980,250 10.1% | -473,000 (-5.00%) | View |
| 2024-02-14 4:15 pm Sale | 13G | NOVA LIFESTYLE INC NVFY | Anson Funds Management LP | 74,300 4.4% | -297,203 (-80.00%) | View |
| 2024-02-14 4:12 pm Purchase | 13G | ZYVERSA THERAPEUTICS INC ZVSA | Anson Funds Management LP | 160,671 9.8% | 160,671 (New Position) | View |
| 2024-02-14 4:11 pm Purchase | 13G | MASSROOTS INC MSRT | Anson Funds Management LP | 1,249,200 7.5% | 1,249,200 (New Position) | View |
| 2024-02-14 4:10 pm Purchase | 13G | 22ND CENTURY GROUP, INC XXII | Anson Funds Management LP | 3,178,491 7.3% | 3,178,491 (New Position) | View |
| 2024-02-14 4:06 pm Purchase | 13G | BIOLASE INC PAR $.001 BIOL | Anson Funds Management LP | 185,127 8.1% | 185,127 (New Position) | View |
| 2024-02-07 5:51 pm Purchase | 13D | VIEW INC VIEW | Anson Funds Management LP | 441,703 9.9% | 354,419 (+406.05%) | View |
| 2023-11-03 5:30 pm Purchase | 13D | NANO DIMENSION LTD SPONSORED A NNDM | Anson Funds Management LP | 20,391,213 8.7% | 2,465,150 (+13.75%) | View |
| 2023-11-01 5:20 pm Unchanged | 13D | MEI PHARMA INC MEIP | Anson Funds Management LP | 1,093,188 16.4% | 0 (Unchanged) | View |
| 2023-10-26 4:37 pm Purchase | 13D | VIEW INC VIEW | Anson Funds Management LP | 87,284 2.2% | 87,284 (New Position) | View |
| 2023-10-24 5:40 pm Purchase | 13D | NANO DIMENSION LTD SPONSORED A NNDM | Anson Funds Management LP | 17,926,063 7.6% | 2,326,200 (+14.91%) | View |
| 2023-10-24 5:00 pm Purchase | 13D | MEI PHARMA INC MEIP | Anson Funds Management LP | 1,093,188 16.4% | 179,000 (+19.58%) | View |
| 2023-10-13 5:00 pm Purchase | 13D | MEI PHARMA INC MEIP | Anson Funds Management LP | 914,188 13.7% | 50,000 (+5.79%) | View |
| 2023-09-26 5:19 pm Purchase | 13D | MEI PHARMA INC MEIP | Anson Funds Management LP | 864,188 13% | 48,060 (+5.89%) | View |
| 2023-09-22 5:21 pm Purchase | 13D | MEI PHARMA INC MEIP | Anson Funds Management LP | 816,128 12.2% | 153,600 (+23.18%) | View |
| 2023-09-15 5:29 pm Unchanged | 13D | MEI PHARMA INC MEIP | Anson Funds Management LP | 662,528 9.9% | 0 (Unchanged) | View |